The Expression of Matrix Metalloproteinases in Eyes with Intraocular Lymphoma

Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1798-1802. doi: 10.1080/09273948.2021.1957122. Epub 2021 Aug 11.

Abstract

Purpose: The purpose of this study is to investigate matrix metalloproteinases (MMPs) expression in human intraocular lymphoma (IOL).

Methods: Two enucleated eyes and seven cell-block samples obtained from patients with IOL who underwent vitrectomy were used. Immunopathological examinations were performed for detection of MMP-2, MMP-9, and TIMP-4 expressions.

Results: In the enucleated eye with primary IOL (PIOL), MMP-2 was negative, and MMP-9 and TIMP-4 were positive in the lymphoma cells, while in the enucleated eye with secondary IOL (SIOL), all the molecules were positive. Among the cell-block samples with PIOL, the positive rate in lymphoma cells of MMP-2, MMP-9, and TIMP-4 was 75%, 100%, and 75%, respectively. In the cell-block samples with SIOL, the positive rates of MMP-2, MMP-9, and TIMP-4 were all 100%.

Conclusions: MMP-2, MMP-9, and TIMP-4 were expressed in lymphoma cells using the specimens of human IOL, suggesting that MMPs may play an important role in the development of IOL.

Keywords: Matrix metalloproteinase; intraocular lymphoma; non-Hodgkin lymphoma; ocular tumor; tumor infiltration.

MeSH terms

  • Humans
  • Intraocular Lymphoma* / diagnosis
  • Matrix Metalloproteinase 2*
  • Matrix Metalloproteinase 9

Substances

  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9